Amylyx Pharmaceuticals, Inc. Other Executive Compensation Disclosures
Every other executive-compensation XBRL fact the company filed (policies, award timing, footnotes, adjustments), newest first. Long text is shortened; the filing has the full text.
- 2026-08-06: Disclosure Rule10b51Arr Adopted; Period 2026-04-01..2026-06-30; Value No.
- 2026-08-06: Disclosure Non Rule10b51Arr Adopted; Period 2026-04-01..2026-06-30; Value No.
- 2026-08-06: Disclosure Non Rule10b51Arr Terminated; Period 2026-04-01..2026-06-30; Value No.
- 2026-08-06: Disclosure Rule10b51Arr Terminated; Period 2026-04-01..2026-06-30; Value No.
| Filed | Disclosure | Qualifiers | Period | Value |
|---|---|---|---|---|
| 2026-08-06 10-Q | Rule10b51Arr Adopted | 2026-04-01..2026-06-30 | No | |
| 2026-08-06 10-Q | Non Rule10b51Arr Adopted | 2026-04-01..2026-06-30 | No | |
| 2026-08-06 10-Q | Non Rule10b51Arr Terminated | 2026-04-01..2026-06-30 | No | |
| 2026-08-06 10-Q | Rule10b51Arr Terminated | 2026-04-01..2026-06-30 | No | |
| 2026-05-07 10-Q | Rule10b51Arr Adopted | 2026-01-01..2026-03-31 | No | |
| 2026-05-07 10-Q | Non Rule10b51Arr Adopted | 2026-01-01..2026-03-31 | No | |
| 2026-05-07 10-Q | Non Rule10b51Arr Terminated | 2026-01-01..2026-03-31 | No | |
| 2026-05-07 10-Q | Rule10b51Arr Terminated | 2026-01-01..2026-03-31 | No | |
| 2026-04-23 DEF 14A | Insider Trading Policies Proc Adopted | 2025-01-01..2025-12-31 | Yes | |
| 2026-04-23 DEF 14A | Award Timing MNPI Disclosure | 2025-01-01..2025-12-31 | Equity Grant Timing We have adopted an Equity Award Grant Policy which established its process for granting equity awards. While we may make grants at any time, it will generally make grants in connection with the hire of a new employee, the promotion of an existing employee, or on an annual basis t… | |
| 2026-04-23 DEF 14A | Award Timing MNPI Considered | 2025-01-01..2025-12-31 | No | |
| 2026-04-23 DEF 14A | MNPI Disclosure Timed For Compensation Val | 2025-01-01..2025-12-31 | No | |
| 2026-04-23 DEF 14A | Pay versus Performance Table | 2025-01-01..2025-12-31 | Pay Versus Performance We are a “smaller reporting company” as defined by Item 10(f)(1) of Regulation S-K and are therefore permitted to provide scaled pay versus performance disclosures. In accordance with rules adopted by the SEC pursuant to the Dodd-Frank Act and Item 402(v) of Regulation S-K, we… | |
| 2026-04-23 DEF 14A | PEO Total Compensation | Individual: JoshuaCohen | 2025-01-01..2025-12-31 | $2.72M |
| 2026-04-23 DEF 14A | PEO Total Compensation | Individual: JustinKlee | 2025-01-01..2025-12-31 | $2.72M |
| 2026-04-23 DEF 14A | PEO Actually Paid Compensation | Individual: JoshuaCohen | 2025-01-01..2025-12-31 | $12.27M |
| 2026-04-23 DEF 14A | PEO Actually Paid Compensation | Individual: JustinKlee | 2025-01-01..2025-12-31 | $12.27M |
| 2026-04-23 DEF 14A | PEO Total Compensation | Individual: JoshuaCohen | 2024-01-01..2024-12-31 | $6.50M |
| 2026-04-23 DEF 14A | PEO Total Compensation | Individual: JustinKlee | 2024-01-01..2024-12-31 | $6.50M |
| 2026-04-23 DEF 14A | PEO Actually Paid Compensation | Individual: JoshuaCohen | 2024-01-01..2024-12-31 | $1.03M |
| 2026-04-23 DEF 14A | PEO Actually Paid Compensation | Individual: JustinKlee | 2024-01-01..2024-12-31 | $1.03M |
| 2026-04-23 DEF 14A | PEO Total Compensation | Individual: JoshuaCohen | 2023-01-01..2023-12-31 | $7.42M |
| 2026-04-23 DEF 14A | PEO Total Compensation | Individual: JustinKlee | 2023-01-01..2023-12-31 | $7.42M |
| 2026-04-23 DEF 14A | PEO Actually Paid Compensation | Individual: JoshuaCohen | 2023-01-01..2023-12-31 | -$6.40M |
| 2026-04-23 DEF 14A | PEO Actually Paid Compensation | Individual: JustinKlee | 2023-01-01..2023-12-31 | -$6.40M |
| 2026-04-23 DEF 14A | Named Executive Officers Footnote | 2025-01-01..2025-12-31 | (1) For 2025 , the PEOs were our Co-Chief Executive Officers, Joshua Cohen and Justin Klee , and the non-PEO NEOs were James Frates and Camille L. Bedrosian, M.D. (2) For 2024 , the PEOs were our Co-Chief Executive Officers, Joshua Cohen and Justin Klee , and the non-PEO NEOs were James Frates and G… | |
| 2026-04-23 DEF 14A | Adjustment To PEO Compensation Footnote | 2025-01-01..2025-12-31 | PEO Summary Compensation Total to Compensation Actually Paid Reconciliation Year Summary Compensation Total for Joshua Cohen ($) Deduction of Equity Awards for Joshua Cohen ($) (a) Addition of Adjusted Equity Awards for Joshua Cohen ($) (b) Compensation Actually Paid to Joshua Cohen ($) 2025 2,719,8… | |
| 2026-04-23 DEF 14A | Adjustment To Compensation | AdjToComp: EqtyAwrdsInSummryCompstnTblForAplblYr; ExecutiveCategory: Peo; Individual: JoshuaCohen | 2025-01-01..2025-12-31 | -$1.47M |
| 2026-04-23 DEF 14A | Adjustment To Compensation | AdjToComp: EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTbl; ExecutiveCategory: Peo; Individual: JoshuaCohen | 2025-01-01..2025-12-31 | $11.02M |
| 2026-04-23 DEF 14A | Adjustment To Compensation | AdjToComp: EqtyAwrdsInSummryCompstnTblForAplblYr; ExecutiveCategory: Peo; Individual: JoshuaCohen | 2024-01-01..2024-12-31 | -$5.27M |
| 2026-04-23 DEF 14A | Adjustment To Compensation | AdjToComp: EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTbl; ExecutiveCategory: Peo; Individual: JoshuaCohen | 2024-01-01..2024-12-31 | -$191.50K |
| 2026-04-23 DEF 14A | Adjustment To Compensation | AdjToComp: EqtyAwrdsInSummryCompstnTblForAplblYr; ExecutiveCategory: Peo; Individual: JoshuaCohen | 2023-01-01..2023-12-31 | -$6.34M |
| 2026-04-23 DEF 14A | Adjustment To Compensation | AdjToComp: EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTbl; ExecutiveCategory: Peo; Individual: JoshuaCohen | 2023-01-01..2023-12-31 | -$7.48M |
| 2026-04-23 DEF 14A | Adjustment To Compensation | AdjToComp: EqtyAwrdsInSummryCompstnTblForAplblYr; ExecutiveCategory: Peo; Individual: JustinKlee | 2025-01-01..2025-12-31 | -$1.47M |
| 2026-04-23 DEF 14A | Adjustment To Compensation | AdjToComp: EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTbl; ExecutiveCategory: Peo; Individual: JustinKlee | 2025-01-01..2025-12-31 | $11.02M |
| 2026-04-23 DEF 14A | Adjustment To Compensation | AdjToComp: EqtyAwrdsInSummryCompstnTblForAplblYr; ExecutiveCategory: Peo; Individual: JustinKlee | 2024-01-01..2024-12-31 | -$5.27M |
| 2026-04-23 DEF 14A | Adjustment To Compensation | AdjToComp: EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTbl; ExecutiveCategory: Peo; Individual: JustinKlee | 2024-01-01..2024-12-31 | -$191.50K |
| 2026-04-23 DEF 14A | Adjustment To Compensation | AdjToComp: EqtyAwrdsInSummryCompstnTblForAplblYr; ExecutiveCategory: Peo; Individual: JustinKlee | 2023-01-01..2023-12-31 | -$6.34M |
| 2026-04-23 DEF 14A | Adjustment To Compensation | AdjToComp: EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTbl; ExecutiveCategory: Peo; Individual: JustinKlee | 2023-01-01..2023-12-31 | -$7.48M |
| 2026-04-23 DEF 14A | Adjustment To Non PEO NEO Compensation Footnote | 2025-01-01..2025-12-31 | Average non-PEO NEOs Summary Compensation Total to Compensation Actually Paid Reconciliation Year Average Summary Compensation Table Total for Non-PEO NEOs ($) Average Deduction of Equity Awards for Non-PEO NEOs ($) (a) Average Addition of Adjusted Equity Awards for Non-PEO NEOs ($) (b) Average Comp… | |
| 2026-04-23 DEF 14A | Adjustment To Compensation | AdjToComp: EqtyAwrdsInSummryCompstnTblForAplblYr; ExecutiveCategory: NonPeoNeo | 2025-01-01..2025-12-31 | -$559.01K |
| 2026-04-23 DEF 14A | Adjustment To Compensation | AdjToComp: EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTbl; ExecutiveCategory: NonPeoNeo | 2025-01-01..2025-12-31 | $4.11M |
| 2026-04-23 DEF 14A | Adjustment To Compensation | AdjToComp: EqtyAwrdsInSummryCompstnTblForAplblYr; ExecutiveCategory: NonPeoNeo | 2024-01-01..2024-12-31 | -$1.66M |
| 2026-04-23 DEF 14A | Adjustment To Compensation | AdjToComp: EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTbl; ExecutiveCategory: NonPeoNeo | 2024-01-01..2024-12-31 | -$608.73K |
| 2026-04-23 DEF 14A | Adjustment To Compensation | AdjToComp: EqtyAwrdsInSummryCompstnTblForAplblYr; ExecutiveCategory: NonPeoNeo | 2023-01-01..2023-12-31 | -$2.39M |
| 2026-04-23 DEF 14A | Adjustment To Compensation | AdjToComp: EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTbl; ExecutiveCategory: NonPeoNeo | 2023-01-01..2023-12-31 | -$3.91M |
| 2026-04-23 DEF 14A | Adjustment To Compensation | AdjToComp: YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstd; ExecutiveCategory: Peo; Individual: JoshuaCohen | 2025-01-01..2025-12-31 | $5.17M |
| 2026-04-23 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrs; ExecutiveCategory: Peo; Individual: JoshuaCohen | 2025-01-01..2025-12-31 | $4.29M |
| 2026-04-23 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYr; ExecutiveCategory: Peo; Individual: JoshuaCohen | 2025-01-01..2025-12-31 | $1.56M |
| 2026-04-23 DEF 14A | Adjustment To Compensation | AdjToComp: YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstd; ExecutiveCategory: Peo; Individual: JoshuaCohen | 2024-01-01..2024-12-31 | $2.78M |
| 2026-04-23 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrs; ExecutiveCategory: Peo; Individual: JoshuaCohen | 2024-01-01..2024-12-31 | -$2.42M |
| 2026-04-23 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYr; ExecutiveCategory: Peo; Individual: JoshuaCohen | 2024-01-01..2024-12-31 | -$552.96K |
| 2026-04-23 DEF 14A | Adjustment To Compensation | AdjToComp: YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstd; ExecutiveCategory: Peo; Individual: JoshuaCohen | 2023-01-01..2023-12-31 | $2.91M |
| 2026-04-23 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrs; ExecutiveCategory: Peo; Individual: JoshuaCohen | 2023-01-01..2023-12-31 | -$5.72M |
| 2026-04-23 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYr; ExecutiveCategory: Peo; Individual: JoshuaCohen | 2023-01-01..2023-12-31 | -$4.66M |
| 2026-04-23 DEF 14A | Adjustment To Compensation | AdjToComp: YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstd; ExecutiveCategory: Peo; Individual: JustinKlee | 2025-01-01..2025-12-31 | $5.17M |
| 2026-04-23 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrs; ExecutiveCategory: Peo; Individual: JustinKlee | 2025-01-01..2025-12-31 | $4.29M |
| 2026-04-23 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYr; ExecutiveCategory: Peo; Individual: JustinKlee | 2025-01-01..2025-12-31 | $1.56M |
| 2026-04-23 DEF 14A | Adjustment To Compensation | AdjToComp: YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstd; ExecutiveCategory: Peo; Individual: JustinKlee | 2024-01-01..2024-12-31 | $2.78M |
| 2026-04-23 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrs; ExecutiveCategory: Peo; Individual: JustinKlee | 2024-01-01..2024-12-31 | -$2.42M |
| 2026-04-23 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYr; ExecutiveCategory: Peo; Individual: JustinKlee | 2024-01-01..2024-12-31 | -$552.96K |
| 2026-04-23 DEF 14A | Adjustment To Compensation | AdjToComp: YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstd; ExecutiveCategory: Peo; Individual: JustinKlee | 2023-01-01..2023-12-31 | $2.91M |
| 2026-04-23 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrs; ExecutiveCategory: Peo; Individual: JustinKlee | 2023-01-01..2023-12-31 | -$5.72M |
| 2026-04-23 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYr; ExecutiveCategory: Peo; Individual: JustinKlee | 2023-01-01..2023-12-31 | -$4.66M |
| 2026-04-23 DEF 14A | Adjustment To Compensation | AdjToComp: YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstd; ExecutiveCategory: NonPeoNeo | 2025-01-01..2025-12-31 | $1.97M |
| 2026-04-23 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrs; ExecutiveCategory: NonPeoNeo | 2025-01-01..2025-12-31 | $1.46M |
| 2026-04-23 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYr; ExecutiveCategory: NonPeoNeo | 2025-01-01..2025-12-31 | $690.00K |
| 2026-04-23 DEF 14A | Adjustment To Compensation | AdjToComp: YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstd; ExecutiveCategory: NonPeoNeo | 2024-01-01..2024-12-31 | $920.44K |
| 2026-04-23 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrs; ExecutiveCategory: NonPeoNeo | 2024-01-01..2024-12-31 | -$1.07M |
| 2026-04-23 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYr; ExecutiveCategory: NonPeoNeo | 2024-01-01..2024-12-31 | -$457.63K |
| 2026-04-23 DEF 14A | Adjustment To Compensation | AdjToComp: YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstd; ExecutiveCategory: NonPeoNeo | 2023-01-01..2023-12-31 | $1.20M |
| 2026-04-23 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrs; ExecutiveCategory: NonPeoNeo | 2023-01-01..2023-12-31 | -$1.77M |
| 2026-04-23 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYr; ExecutiveCategory: NonPeoNeo | 2023-01-01..2023-12-31 | -$2.65M |
| 2026-04-23 DEF 14A | Adjustment To Compensation | AdjToComp: FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYr; ExecutiveCategory: NonPeoNeo | 2023-01-01..2023-12-31 | -$696.71K |
| 2026-04-23 DEF 14A | Compensation Actually Paid Vs Total Shareholder Return | 2025-01-01..2025-12-31 | ||
| 2026-04-23 DEF 14A | Compensation Actually Paid Vs Net Income | 2025-01-01..2025-12-31 | ||
| 2026-03-03 10-K | Material Terms Of Trading Arrangement | 2025-10-01..2025-12-31 | (a) None. (b) Rule 10b5-1 Trading Arrangements During the three months ended December 31, 2025 , no officers or directors of the Company (as defined in Rule 16a-1(f)) adopted , modified or terminated a “Rule 10b5-1 trading arrangement” or a “non-Rule 10b5-1 trading arrangement,” as each term is defi… | |
| 2026-03-03 10-K | Rule10b51Arr Adopted | 2025-10-01..2025-12-31 | No | |
| 2026-03-03 10-K | Non Rule10b51Arr Adopted | 2025-10-01..2025-12-31 | No | |
| 2026-03-03 10-K | Rule10b51Arr Terminated | 2025-10-01..2025-12-31 | No | |
| 2026-03-03 10-K | Non Rule10b51Arr Terminated | 2025-10-01..2025-12-31 | No |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Enliven Therapeutics, Inc. (ELVN) | United States | $3.307B | -35.07 |
| Arcutis Biotherapeutics, Inc. (ARQT) | United States | $3.303B | 115.47 |
| Arcus Biosciences, Inc. (RCUS) | United States | $3.188B | -8.52 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| Dyne Therapeutics, Inc. (DYN) | United States | $3.084B | -7.09 |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 | |
| ACADIA PHARMACEUTICALS INC (ACAD) | United States | $3.823B | 11.45 |
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 | |
| PRECIGEN, INC. (PGEN) | United States | $2.757B | -12.94 |